INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,228 | -25.4% | 20,270 | 0.0% | 0.00% | – |
| Q2 2023 | $184,052 | +40.4% | 20,270 | -0.1% | 0.00% | – |
| Q1 2023 | $131,119 | +8.2% | 20,297 | +6.2% | 0.00% | – |
| Q4 2022 | $121,132 | +2.7% | 19,106 | 0.0% | 0.00% | – |
| Q3 2022 | $118,000 | -30.2% | 19,106 | 0.0% | 0.00% | – |
| Q2 2022 | $169,000 | +0.6% | 19,106 | -4.0% | 0.00% | – |
| Q1 2022 | $168,000 | -17.2% | 19,905 | 0.0% | 0.00% | – |
| Q4 2021 | $203,000 | -53.0% | 19,905 | -10.4% | 0.00% | – |
| Q3 2021 | $432,000 | +76.3% | 22,221 | +59.3% | 0.00% | – |
| Q2 2021 | $245,000 | +47.6% | 13,949 | 0.0% | 0.00% | – |
| Q1 2021 | $166,000 | -22.1% | 13,949 | +12.7% | 0.00% | – |
| Q4 2020 | $213,000 | – | 12,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |